Hypokalemic periodic paralysis associated with thyrotoxicosis, renal tubular acidosis and nephrogenic diabetes insipidus. 2010

Eun Joo Im, and Jung Min Lee, and Ji Hyun Kim, and Sang Ah Chang, and Sung Dae Moon, and Yu Bae Ahn, and Hyun Shik Son, and Bong Yun Cha, and Kwang Woo Lee, and Ho Young Son
Division of Endocrinology and Metabolism, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.

A 19-year-old girl presented at our emergency room with hypokalemic periodic paralysis. She had a thyrotoxic goiter and had experienced three paralytic attacks during the previous 2 years on occasions when she stopped taking antithyroid drugs. In addition to thyrotoxic periodic paralysis (TPP), she had metabolic acidosis, urinary potassium loss, polyuria and polydipsia. Her reduced ability to acidify urine during spontaneous metabolic acidosis was confirmed by detection of coexisting distal renal tubular acidosis (RTA). The polyuria and polydipsia were caused by nephrogenic diabetes insipidus, which was diagnosed using the water deprivation test and vasopressin administration. Her recurrent and frequent paralytic attacks may have been the combined effects of thyrotoxicosis and RTA. Although the paralytic attack did not recur after improving the thyroid function, mild acidosis and nephrogenic DI have been remained subsequently. Patients with TPP, especially females with atypical metabolic features, should be investigated for possible precipitating factors.

UI MeSH Term Description Entries
D011141 Polyuria Urination of a large volume of urine with an increase in urinary frequency, commonly seen in diabetes (DIABETES MELLITUS; DIABETES INSIPIDUS). Polyurias
D011441 Propylthiouracil A thiourea antithyroid agent. Propythiouracil inhibits the synthesis of thyroxine and inhibits the peripheral conversion of throxine to tri-iodothyronine. It is used in the treatment of hyperthyroidism. (From Martindale, The Extra Pharmacopeoia, 30th ed, p534) 6-Propyl-2-Thiouracil,6 Propyl 2 Thiouracil
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D005260 Female Females
D006042 Goiter Enlargement of the THYROID GLAND that may increase from about 20 grams to hundreds of grams in human adults. Goiter is observed in individuals with normal thyroid function (euthyroidism), thyroid deficiency (HYPOTHYROIDISM), or hormone overproduction (HYPERTHYROIDISM). Goiter may be congenital or acquired, sporadic or endemic (GOITER, ENDEMIC). Goiters
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000141 Acidosis, Renal Tubular A group of genetic disorders of the KIDNEY TUBULES characterized by the accumulation of metabolically produced acids with elevated plasma chloride, hyperchloremic metabolic ACIDOSIS. Defective renal acidification of URINE (proximal tubules) or low renal acid excretion (distal tubules) can lead to complications such as HYPOKALEMIA, hypercalcinuria with NEPHROLITHIASIS and NEPHROCALCINOSIS, and RICKETS. Renal Tubular Acidosis,Renal Tubular Acidosis, Type I,Renal Tubular Acidosis, Type II,Type I Renal Tubular Acidosis,Type II Renal Tubular Acidosis,Acidosis, Renal Tubular, Type I,Acidosis, Renal Tubular, Type II,Autosomal Dominant Distal Renal Tubular Acidosis,Classic Distal Renal Tubular Acidosis,Distal Renal Tubular Acidosis,Proximal Renal Tubular Acidosis,RTA, Classic Type,RTA, Distal Type, Autosomal Dominant,RTA, Gradient Type,RTA, Proximal Type,Renal Tubular Acidosis 1,Renal Tubular Acidosis I,Renal Tubular Acidosis II,Renal Tubular Acidosis, Distal, Autosomal Dominant,Renal Tubular Acidosis, Proximal,Renal Tubular Acidosis, Proximal, with Ocular Abnormalities,Classic Type RTA,Classic Type RTAs,Gradient Type RTA,Gradient Type RTAs,Proximal Type RTA,Proximal Type RTAs,RTAs, Classic Type,RTAs, Gradient Type,RTAs, Proximal Type
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013956 Antithyroid Agents Agents that are used to treat hyperthyroidism by reducing the excessive production of thyroid hormones. Antithyroid Agent,Antithyroid Drug,Goitrogen,Goitrogens,Thyroid Antagonists,Antithyroid Drugs,Antithyroid Effect,Antithyroid Effects,Agent, Antithyroid,Agents, Antithyroid,Antagonists, Thyroid,Drug, Antithyroid,Drugs, Antithyroid,Effect, Antithyroid,Effects, Antithyroid
D013971 Thyrotoxicosis A hypermetabolic syndrome caused by excess THYROID HORMONES which may come from endogenous or exogenous sources. The endogenous source of hormone may be thyroid HYPERPLASIA; THYROID NEOPLASMS; or hormone-producing extrathyroidal tissue. Thyrotoxicosis is characterized by NERVOUSNESS; TACHYCARDIA; FATIGUE; WEIGHT LOSS; heat intolerance; and excessive SWEATING. Thyrotoxicoses

Related Publications

Eun Joo Im, and Jung Min Lee, and Ji Hyun Kim, and Sang Ah Chang, and Sung Dae Moon, and Yu Bae Ahn, and Hyun Shik Son, and Bong Yun Cha, and Kwang Woo Lee, and Ho Young Son
January 2021, Case reports in endocrinology,
Eun Joo Im, and Jung Min Lee, and Ji Hyun Kim, and Sang Ah Chang, and Sung Dae Moon, and Yu Bae Ahn, and Hyun Shik Son, and Bong Yun Cha, and Kwang Woo Lee, and Ho Young Son
January 1981, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion,
Eun Joo Im, and Jung Min Lee, and Ji Hyun Kim, and Sang Ah Chang, and Sung Dae Moon, and Yu Bae Ahn, and Hyun Shik Son, and Bong Yun Cha, and Kwang Woo Lee, and Ho Young Son
July 1995, Pediatric neurology,
Eun Joo Im, and Jung Min Lee, and Ji Hyun Kim, and Sang Ah Chang, and Sung Dae Moon, and Yu Bae Ahn, and Hyun Shik Son, and Bong Yun Cha, and Kwang Woo Lee, and Ho Young Son
October 2022, Revue neurologique,
Eun Joo Im, and Jung Min Lee, and Ji Hyun Kim, and Sang Ah Chang, and Sung Dae Moon, and Yu Bae Ahn, and Hyun Shik Son, and Bong Yun Cha, and Kwang Woo Lee, and Ho Young Son
March 2013, Indian pediatrics,
Eun Joo Im, and Jung Min Lee, and Ji Hyun Kim, and Sang Ah Chang, and Sung Dae Moon, and Yu Bae Ahn, and Hyun Shik Son, and Bong Yun Cha, and Kwang Woo Lee, and Ho Young Son
January 1985, European neurology,
Eun Joo Im, and Jung Min Lee, and Ji Hyun Kim, and Sang Ah Chang, and Sung Dae Moon, and Yu Bae Ahn, and Hyun Shik Son, and Bong Yun Cha, and Kwang Woo Lee, and Ho Young Son
November 1987, Critical care medicine,
Eun Joo Im, and Jung Min Lee, and Ji Hyun Kim, and Sang Ah Chang, and Sung Dae Moon, and Yu Bae Ahn, and Hyun Shik Son, and Bong Yun Cha, and Kwang Woo Lee, and Ho Young Son
May 1992, Internal medicine (Tokyo, Japan),
Eun Joo Im, and Jung Min Lee, and Ji Hyun Kim, and Sang Ah Chang, and Sung Dae Moon, and Yu Bae Ahn, and Hyun Shik Son, and Bong Yun Cha, and Kwang Woo Lee, and Ho Young Son
July 1984, Postgraduate medical journal,
Eun Joo Im, and Jung Min Lee, and Ji Hyun Kim, and Sang Ah Chang, and Sung Dae Moon, and Yu Bae Ahn, and Hyun Shik Son, and Bong Yun Cha, and Kwang Woo Lee, and Ho Young Son
April 2019, Indian pediatrics,
Copied contents to your clipboard!